Related Experiment Video
Updated: Feb 8, 2026
06:05
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.8K
Sugammadex: An Update.
Tiberiu Ezri1,2, Mona Boaz3, Alexander Sherman1
1Departments of Anesthesia, Wolfson Medical Center, affiliated to Tel Aviv University, Tel Aviv, Israel.
Summary
This review covers current knowledge and discussions on sugammadex in anesthesia and critical care. It focuses on recent updates rather than a complete clinical overview.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Sugammadex is a selective relaxant binding agent used in anesthesia.
- Its application in critical care settings is an evolving area of interest.
- Understanding its recent developments is crucial for clinical practice.
Purpose of the Study:
- To present updated information on sugammadex.
- To discuss current debates surrounding its use.
- To highlight recent advancements relevant to anesthesia and critical care.
Main Methods:
- Literature review of recent publications.
- Synthesis of current knowledge and expert opinions.
- Focus on contemporary debates and applications.
Main Results:
- Recent studies and discussions provide new insights into sugammadex.
- The review highlights ongoing debates regarding its optimal use.
- Emerging data informs its application in specific patient populations.
Conclusions:
- Sugammadex continues to be a significant agent in modern anesthesia.
- Further research and discussion are needed for its expanded role in critical care.
- Clinicians should stay abreast of the latest evidence regarding sugammadex.
